Drugs / 17D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05859490 | Aug 2023 → Nov 2025 overdue | yellow fever | Oregon Health and Science University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 17D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05859490 ↗ |
| Modality | Vaccine | “yellow fever vaccine 17D” NCT05859490 ↗ |
| Route | Subcutaneous | “administered subcutaneously once.” NCT05859490 ↗ |